121 related articles for article (PubMed ID: 12942318)
1. Lipid, nitrogen, water and energy content of a single stool sample in healthy children and children with cystic fibrosis.
Van den Neucker AM; Forget PP; van Kreel B
Eur J Pediatr; 2003 Nov; 162(11):764-6. PubMed ID: 12942318
[TBL] [Abstract][Full Text] [Related]
2. Comparison of near infrared reflectance analysis of fecal fat, nitrogen and water with conventional methods, and fecal energy content.
Neucker AV; Bijleveld CM; Wolthers BG; Swaaneburg JC; Kester AD; Kreel Bv; Forget PP
Clin Biochem; 2002 Feb; 35(1):29-33. PubMed ID: 11937075
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis.
Tardelli AC; Camargos PA; Penna FJ; Sarkis PF; Guimarães EV
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):178-81. PubMed ID: 22922373
[TBL] [Abstract][Full Text] [Related]
4. Comparison of steatocrit and fat absorption in persons with cystic fibrosis.
Wagner MH; Bowser EK; Sherman JM; Francisco MP; Theriaque D; Novak DA
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):202-5. PubMed ID: 12187298
[TBL] [Abstract][Full Text] [Related]
5. Acid steatocrit determination is not helpful in cystic fibrosis patients without or with mild steatorrhea.
Walkowiak J; Lisowska A; Blask-Osipa A; Drzymała-Czyz S; Sobkowiak P; Cichy W; Breborowicz A; Herzig KH; Radzikowski A
Pediatr Pulmonol; 2010 Mar; 45(3):249-54. PubMed ID: 20146370
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
Walkowiak J; Herzig KH; Strzykala K; Lisowska A; Przyslawski J; Grzymislawski M; Krawczynski M
Med Wieku Rozwoj; 2003; 7(2):149-55. PubMed ID: 12878785
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
Proesmans M; De Boeck K
Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
9. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
De Curtis M; Santamaria F; Ercolini P; Vittoria L; De Ritis G; Garofalo V; Ciccimarra F
Arch Dis Child; 1992 Sep; 67(9):1082-5. PubMed ID: 1417050
[TBL] [Abstract][Full Text] [Related]
10. Energy content of stools in normal healthy controls and patients with cystic fibrosis.
Murphy JL; Wootton SA; Bond SA; Jackson AA
Arch Dis Child; 1991 Apr; 66(4):495-500. PubMed ID: 2031608
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
[TBL] [Abstract][Full Text] [Related]
13. Monitoring steatorrhoea in cystic fibrosis.
De Curtis M; Santamaria F; Ercolini P; Sica G; Bianco V; Ciccimarra F
Eur J Pediatr; 1994 Jun; 153(6):416-8. PubMed ID: 8088296
[TBL] [Abstract][Full Text] [Related]
14. Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Leus J; Van Biervliet S; Robberecht E
Eur J Pediatr; 2000 Aug; 159(8):563-8. PubMed ID: 10968231
[TBL] [Abstract][Full Text] [Related]
15. [Rationalization of the quantitative determination of fecal fat].
Bornschein W; Lessner F
Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):333-42. PubMed ID: 4092655
[TBL] [Abstract][Full Text] [Related]
16. Acid steatocrit: a reliable screening tool for steatorrhoea.
Van den Neucker AM; Kerkvliet EM; Theunissen PM; Forget PP
Acta Paediatr; 2001 Aug; 90(8):873-5. PubMed ID: 11529533
[TBL] [Abstract][Full Text] [Related]
17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
18. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
Regele S; Henker J; Münch R; Barbier Y; Stern M
J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
[TBL] [Abstract][Full Text] [Related]
19. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
20. Markers for the validation of reported dietary intake in adults with cystic fibrosis.
Olveira G; Olveira C; Casado-Miranda E; Padilla A; Dorado A; Rojo-Martinez G; Porras N; Garcia-Escobar E; Soriguer F
J Am Diet Assoc; 2009 Oct; 109(10):1704-11. PubMed ID: 19782169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
